You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0248 The impact of therapy on anti-carbamylated protein antibody isotypes and serostatus in patients with early ra treated with abatacept and methotrexate

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0248 The impact of therapy on anti-carbamylated protein antibody isotypes and serostatus in patients with early ra treated with abatacept and methotrexate
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 2017601
Jul 20172000
Aug 2017800
Sep 20171801
Oct 20171002
Nov 2017400
Dec 20172600
Jan 20181204
Feb 20181200
Mar 2018600
Apr 20181400
May 20181602
Jun 20181200
Jul 2018200
Aug 2018401
Sep 2018401
Oct 2018800
Dec 2018601
Jan 2019201
Feb 2019600
Mar 2019203
Apr 2019202
May 2019002
Jun 2019401
Jul 2019404
Aug 2019803
Sep 2019002
Oct 2019201
Nov 2019202
Jan 2020001
Feb 2020200
Mar 20201004
Apr 2020003
May 2020001
Jun 2020401
Jul 2020604
Aug 2020201
Sep 2020801
Oct 20202600
Nov 2020801
Dec 20201802
Jan 2021802
Feb 2021001
Mar 2021001
Apr 2021202
May 2021001
Jul 2021003
Aug 2021003
Sep 2021002
Oct 20212019
Nov 20210014
Dec 2021202
Jan 2022400
Feb 2022200
Mar 2022002
Apr 2022200
May 2022404
Jun 20221403
Jul 20221000
Aug 2022602
Sep 2022205
Oct 2022603
Nov 2022200
Dec 2022601
Jan 2023202
Feb 2023200
Mar 2023801
Apr 2023400
May 2023202
Jun 2023200
Jul 2023403
Aug 2023001
Sep 2023001
Nov 2023001
Dec 20231800
Jan 2024603
Feb 2024200
Mar 2024200
Apr 20241204
May 2024400
Jun 2024301
Jul 2024401
Aug 2024800
Total4590143